Neurocrine Biosciences | NBIX - Kreditur Perdagangan





Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Gilead Sciences USD 715M 93M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pfizer USD 5.02B 142M 2025-09
Prothena USD 5.88M 4.63M 2025-12
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Repligen USD 30.01M 584K 2025-12
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xoma USD 2.65M 1.52M 2025-09